Nektar Announces New Clinical Study Collaboration with Cellular Biomedicine
27 Sep 2023 //
PR NEWSWIRE
Cellular Origins Partners With ScaleReady to Simplify Cell Therapy Manufacturing
11 May 2023 //
BUSINESSWIRE
CBMG Receives FDA RMAT & FTD for Bi-Specific Anti-CD19/CD20 CAR-T Cell Therapy
12 Jan 2022 //
PRNEWSWIRE
FDA Clears CBMG`s IND for Bi-Specific Anti-CD19/CD20 CAR-T Cell Therapy
13 Dec 2021 //
PRNEWSWIRE
CBMG Holdings Completes $120 Million in Series A Funding
30 Sep 2021 //
PRNEWSWIRE
Cellular Biomedicine Group, Inc. Announces Completion of Merger
19 Feb 2021 //
PRNEWSWIRE
Cellular Biomedicine Group, Inc. Announces Completion of Merger
19 Feb 2021 //
BIOSPACE
Cellular Biomedicine Group, Inc. Announces Completion of Merger
19 Feb 2021 //
BIOSPACE
Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine
28 Jan 2021 //
BIOSPACE
Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH
04 Dec 2020 //
PRNEWSWIRE
Novartis’ CAR-T partner in China wraps $383M take-private deal engineered by CEO
14 Aug 2020 //
ENDPTS
Cellular Biomedicine Group (CBMG) Enters Into Definitive Merger Agreement
12 Aug 2020 //
PRNEWSWIRE
Cellular Biomedicine Group (CBMG) Presents Poster of TCRs Targeting AACR
22 Jun 2020 //
PRNEWSWIRE